Literature DB >> 8453783

Detection of autoantibodies against hGH in sera of idiopathic hypopituitary children.

A S Llera1, A I Cardoso, R R Stumpo, A S Martinez, J J Heinrich, E Poskus.   

Abstract

Using reliable displacement radiobinding assay (RBA) and ELISA, the existence of anti-human growth hormone autoantibodies (hGHAA) was confirmed in idiopathic hypopituitary patients with growth impairment. Six of 35 hypopituitary patients (17.1%) and 1/85 (1.2%) control children proved positive for hGHAA by RBA (>control mean + 3 SD). IgG isotype-hGHAA by ELISAIgG (> control mean + 3 SD) were positive for 6/34 (17.7%) and 3/85 (3.5% hypopituitary and control children, respectively. Due to an asymmetry to the right of the ELISAIgG distribution, an alternative cutoff based on a nonparametric method was obtained, and positive results for hypopituitary children increased to 10/34 (29.4%). Three of 34 hypopituitary patients but no control children were positive for hGHAA of IgM isotype. The hGHAA were detected in children with or without perinatal problems. These autoantibodies may represent markers of a major autoimmune process involving a portion of the anterior pituitary and may contribute to the development of hypopituitarism in over 15% of hypopituitary children.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453783     DOI: 10.1006/clin.1993.1014

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  3 in total

Review 1.  Pituitary autoimmune disease: nuances in clinical presentation.

Authors:  A Glezer; M D Bronstein
Journal:  Endocrine       Date:  2012-03-17       Impact factor: 3.633

2.  Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera.

Authors:  Asaf Madi; Sharron Bransburg-Zabary; Ayala Maayan-Metzger; Gittit Dar; Eshel Ben-Jacob; Irun R Cohen
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

3.  Organ- and non-organ-specific auto-antibodies in children with hypopituitarism on growth hormone therapy.

Authors:  M Maghnie; R Lorini; L Vitali; N Mastricci; A M Carrà; F Severi
Journal:  Eur J Pediatr       Date:  1995-06       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.